← The Wire
CUENasdaq
Cue Biopharma, Inc.
Pharmaceutical Preparations · DE · CIK 1645460
Developing injectable therapeutics to selectively engage and modulate disease-specific T cells for autoimmune and inflammatory diseases
red 8-K · 90d
$103M
Market cap
$30.43
Last close
+19.9%
1D
-1.0%
5D
164K
Volume
Price · last 39 sessions+1.9%
May 4L $20.03 · H $35.73Jun 29
176
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AMar 27, 2026DEFA14ADEFA14AMay 27, 2025DEFA14ADEFA14AApr 25, 2025DEFA14ADEFA14AMay 24, 2024DEFA14ADEFA14AApr 26, 2024DEFA14ADEFA14AApr 28, 2023DEFA14ADEFA14AApr 29, 2022DEFA14ADEFA14AApr 26, 2021DEFA14ADEFA14AMay 29, 2020DEFA14ADEFA14AJun 18, 2019DEFA14ADEFA14AMay 29, 2018DEFA14ADEFA14AApr 30, 2018
Insider Activity
In the 90 days to Dec 30, 2025: 1 insider bought $100K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 86,947 | $0.32 | $28K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 78,116 | $0.31 | $24K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,417 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 77,148 | $0.30 | $23K |
| Dec 30, 2025 | Sarraf PashaDirector | Buy | 4,229 | $0.31 | $1K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance